|Topic:||Initial National Priorities for Comparative Effectiveness Research|
THE NATIONAL ACADEMIES
Institute of Medicine
Board on Health Care Services
Committee on Comparative Effectiveness Research Prioritization
Monday, June 29, 2009
138 Dirksen Senate Office Bldg. – 11:00 a.m.
SVC-210, The Capitol Bldg. – 12:00 p.m.
1139E Longworth House Office Bldg. – 1:00 p.m.
1105 Longworth House Office Bldg. – 3:30 p.m.
Initial National Priorities for Comparative Effectiveness Research
Comparative effectiveness research (CER) identifies what works best for which patients under what circumstances. Congress, in the American Recovery and Reinvestment Act (ARRA) of 2009 (P.L. 111-5), tasked the Institute of Medicine (IOM) with recommending national priorities for research questions to be addressed by CER and supported by ARRA funds. In this new report, Initial National Priorities for Comparative Effectiveness Research, the authoring committee establishes a working definition of CER, develops a priority list of research topics to be undertaken with ARRA funding using broad stakeholder input, and identifies the necessary requirements to support a robust and sustainable CER enterprise.
These series of briefings were for members of Congress and congressional staff only. The report was publicly released on June 30, 2009 and can be found, in its entirety, on the Web site of the National Academies Press.